Patterns of Benzodiazepine Use and Excess Risk of All-Cause Mortality in the Elderly: A Nationwide Cohort Study

被引:20
作者
Mathieu, Clement [1 ]
Joly, Pierre [2 ]
Jacqmin-Gadda, Helene [2 ]
Wanneveich, Mathilde [2 ]
Begaud, Bernard [1 ,3 ]
Pariente, Antoine [1 ,3 ]
机构
[1] Univ Bordeaux, INSERM, Team Pharmacoepidemiol, U1219,BPH, F-33000 Bordeaux, France
[2] Univ Bordeaux, INSERM, Team Biostat, U1219,BPH, F-33000 Bordeaux, France
[3] CHU Bordeaux, Serv Pharmacol Med, Pole Sante Publ, Ctr Pharmacovigilance Bordeaux, F-33000 Bordeaux, France
关键词
TIME BIAS; CLAIMS; DATABASES; DEMENTIA; PRESCRIPTION; DRUGS;
D O I
10.1007/s40264-020-00992-7
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Introduction Despite the risks associated with their use, benzodiazepines remain used more widely than wisely. In this context, a better understanding of how their patterns of use can be associated with an increased risk of death appears essential. Indeed, the studies that investigated this association so far are inconsistent and question the influence of potential biases. Objective The objective of this study was to investigate the association of various patterns of benzodiazepine use with all-cause mortality. Methods A nationwide cohort of non-prevalent benzodiazepine users aged >= 65 years was identified using French healthcare insurance system claims databases. Exposure to benzodiazepines considered short-term, chronic (defined as a cumulated >= 6-month period over the previous 12 months), ongoing, and discontinued use. Using a Cox model, adjusted hazard ratios for all-cause mortality were estimated according to benzodiazepine patterns of use; exposure and confounders were treated as time-dependent variables. Results In the cohort of 54,958 individuals aged >= 65 years, adjusted hazard ratios for all-cause mortality and benzodiazepines were 2.26 (95% confidence interval 1.96-2.61) for short-term use, 3.86 (3.04-4.90) for chronic use-discontinued, and 3.05 (2.17-4.29) for chronic use-ongoing. At age 80 years, these were 1.62 (1.48-1.79), 2.00 (1.82-2.19) and 1.13 (1.02-1.26), respectively. Adjusted hazard ratios show similar decreases with age for all patterns of benzodiazepine use. Conclusions These findings confirm the existence of an excess risk of mortality associated with benzodiazepine use and provide pattern- and age-specific estimates. Higher risks were observed for patients aged < 80 years, short-term use, or chronic use recently interrupted. If the two latter can relate to an indication bias, the associations found for ongoing chronic use and short-term use conversely support a potential causal hypothesis.
引用
收藏
页码:53 / 62
页数:10
相关论文
共 42 条
[21]   The Use of Hypnotics and Mortality - A Population-Based Retrospective Cohort Study [J].
Lan, Tzuo-Yun ;
Zeng, Ya-Fang ;
Tang, Gau-Jun ;
Kao, Hui-Chuan ;
Chiu, Hsien-Jane ;
Lan, Tsuo-Hung ;
Ho, Hsiao-Feng .
PLOS ONE, 2015, 10 (12)
[22]   A Systematic Review of Opioid and Benzodiazepine Misuse in Older Adults [J].
Maree, Rachel D. ;
Marcum, Zachary A. ;
Saghafi, Ester ;
Weiner, Debra K. ;
Karp, Jordan F. .
AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2016, 24 (11) :949-963
[23]   Potentially inappropriate use of benzodiazepines and z-drugs in the older population-analysis of associations between long-term use and patient-related factors [J].
Mokhar, Aliaksandra ;
Tillenburg, Niklas ;
Dirmaier, Joerg ;
Kuhn, Silke ;
Haerter, Martin ;
Verthein, Uwe .
PEERJ, 2018, 6
[24]   Prescription medicine use by pedestrians and the risk of injurious road traffic crashes: A case-crossover study [J].
Nee, Melanie ;
Avalos, Marta ;
Luxcey, Audrey ;
Contrand, Benjamin ;
Salmi, Louis-Rachid ;
Fourrier-Reglat, Annie ;
Gadegbeku, Blandine ;
Lagarde, Emmanuel ;
Orriols, Ludivine .
PLOS MEDICINE, 2017, 14 (07)
[25]   Risk of suicide attempts after benzodiazepine and/or antidepressant use [J].
Neutel, CI ;
Patten, SB .
ANNALS OF EPIDEMIOLOGY, 1997, 7 (08) :568-574
[26]   Comparison of health insurance claims and patient interviews in assessing drug use: data from the Three-City (3C) Study [J].
Noize, Pernelle ;
Bazin, Fabienne ;
Dufouil, Carole ;
Lechevallier-Michel, Nathalie ;
Ancelin, Marie-Laure ;
Dartigues, Jean-Francois ;
Tzourio, Christophe ;
Moore, Nicholas ;
Fourrier-Reglat, Annie .
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 (04) :310-319
[27]   Benzodiazepine Use in the United States [J].
Olfson, Mark ;
King, Marissa ;
Schoenbaum, Michael .
JAMA PSYCHIATRY, 2015, 72 (02) :136-142
[28]   Road traffic crash risk associated with benzodiazepine and z-hypnotic use after implementation of a colour-graded pictogram: a responsibility study [J].
Orriols, Ludivine ;
Luxcey, Audrey ;
Contrand, Benjamin ;
Gadegbeku, Blandine ;
Delorme, Bernard ;
Tricotel, Aurore ;
Moore, Nicholas ;
Salmi, Louis-Rachid ;
Lagarde, Emmanuel .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 82 (06) :1625-1635
[29]   Overview of drug data within French health insurance databases and implications for pharmacoepidemiological studies [J].
Palmaro, Aurore ;
Moulis, Guillaume ;
Despas, Fabien ;
Dupouy, Julie ;
Lapeyre-Mestre, Maryse .
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (06) :616-624
[30]   Benzodiazepines and injurious falls in community dwelling elders [J].
Pariente, Antoine ;
Dartigues, Jean-Francois ;
Benichou, Jacgues ;
Letenneur, Luc ;
Moore, Nicholas ;
Fourrier-Reglat, Annie .
DRUGS & AGING, 2008, 25 (01) :61-70